Status:
COMPLETED
Improving New Learning and Memory in Traumatic Brain Injury
Lead Sponsor:
Kessler Foundation
Collaborating Sponsors:
U.S. Department of Education
Conditions:
Traumatic Brain Injury
Eligibility:
All Genders
18-59 years
Phase:
NA
Brief Summary
The current study is a double-blind, placebo-control randomized clinical trial examining the efficacy of memory retraining in Traumatic Brain Injury (TBI). Impairment in higher level cognitive process...
Detailed Description
Impairments in higher level cognitive processing, such as new learning and memory, are among the most common deficits in individuals with Traumatic Brain Injury (TBI) and such deficits have been shown...
Eligibility Criteria
Inclusion
- English as primary language
- Diagnosis of TBI, at least one year post-injury
Exclusion
- ages less than 18 or greater than 59
- previous head injury, stroke, seizures, or any other significant neurological history
- Medications: persons on steroids, benzodiazepines, and/or neuroleptics will not be included
- Individuals with an active diagnosis of Major Depressive Disorder, Schizophrenia, Bipolar Disorder I or II will be excluded from the study
- Significant history of drug or alcohol abuse
- Poor Visual Acuity (corrected vision in worse eye \< 20/60), diplopia, or nystagmus
- Inability to understand directions and following one, two, and three step commands
- Intact New Learning and Memory: Only individuals that show impaired performance on a memory test will be included in the study
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2014
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01207375
Start Date
January 1 2008
End Date
October 1 2014
Last Update
April 3 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kessler Foundation Research Center
West Orange, New Jersey, United States, 07052